Global consensus from the PHITT consortium surrounding an interim chemotherapy guidance for the treatment of children with hepatoblastoma, hepatocellular neoplasm – not otherwise specified (HCN-NOS), hepatocellular carcinoma and fibrolamellar carcinoma after trial closure

Global consensus from the PHITT consortium surrounding an interim chemotherapy guidance for the treatment of children with hepatoblastoma, hepatocellular neoplasm – not otherwise specified (HCN-NOS), hepatocellular carcinoma and fibrolamellar carcinoma after trial closure

Malignant liver tumors affecting children and adolescents are rare. In order to adequately study liver tumors occurring in this patient population and establish a more uniform approach to therapy, the three primary liver tumor consortia, SIOPEL (mainly European), COG (mainly North American) and JCCG...

Full description

Saved in:
Bibliographic Details
Main Authors: Irene Schmid, Allison F. O’Neill, Kenichiro Watanabe, Isabelle Aerts, Sophie Branchereau, Penelope R. Brock, Madhumita Dandapani, Brice Fresneau, Jim Geller, Tomoro Hishiki, Danielle Ingham, Kathelijne Kraal, Milind Ronghe, Greg Tiao, Angela Trobaugh-Lotrario, Arun Rangaswami, Michael J. Sullivan, Jozsef Zsiros, Eiso Hiyama, Marcio Malogolowkin, Marc Ansari
Format: Article
Language:English
Published: Elsevier 2025-06-01
Series:EJC Paediatric Oncology
Subjects:
Hepatoblastoma
Hepatocellular Carcinoma
Hepatocellular Neoplasm – Not Otherwise Specified
Interim guidance
Children
Chemotherapy
Online Access:http://www.sciencedirect.com/science/article/pii/S2772610X25000236
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items